These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23209006)

  • 41. Accuracy in parameter estimation for targeted effects in structural equation modeling: sample size planning for narrow confidence intervals.
    Lai K; Kelley K
    Psychol Methods; 2011 Jun; 16(2):127-48. PubMed ID: 21417531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Roaming through methodology. XXXIV. Limitations of predictive models].
    Visser M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(23):1109-12. PubMed ID: 11450603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sample size planning for longitudinal models: accuracy in parameter estimation for polynomial change parameters.
    Kelley K; Rausch JR
    Psychol Methods; 2011 Dec; 16(4):391-405. PubMed ID: 21744968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quick calculation for sample size while controlling false discovery rate with application to microarray analysis.
    Liu P; Hwang JT
    Bioinformatics; 2007 Mar; 23(6):739-46. PubMed ID: 17237060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance or relevance: what do you use in large samples? About p values, confidence intervals, and effect sizes.
    Veldhuizen I; Pasker-De Jong P; Atsma F
    Transfusion; 2012 Jun; 52(6):1169-71. PubMed ID: 22168259
    [No Abstract]   [Full Text] [Related]  

  • 47. Statistical analysis. Receiver operating characteristic (ROC) curve and lipid peroxidation.
    Schisterman EF
    Methods Mol Biol; 2002; 196():343-52. PubMed ID: 12152214
    [No Abstract]   [Full Text] [Related]  

  • 48. Two-sided tolerance intervals for balanced and unbalanced random effects models.
    Hoffman D; Kringle R
    J Biopharm Stat; 2005; 15(2):283-93. PubMed ID: 15796296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 'goddess of randomisation' in small samples.
    Bangdiwala SI
    Int J Inj Contr Saf Promot; 2011 Mar; 18(1):89-93. PubMed ID: 21409678
    [No Abstract]   [Full Text] [Related]  

  • 50. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the performance of different procedures for constructing confidence intervals for coefficient alpha: a simulation study.
    Cui Y; Li J
    Br J Math Stat Psychol; 2012 Nov; 65(3):467-98. PubMed ID: 22295951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two confidence interval approaches on the dependability coefficient in a two-factor crossed design.
    Ting N; Cappelleri JC; Bushmakin AG
    J Biopharm Stat; 2009 Jul; 19(4):610-24. PubMed ID: 20183429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interpretation of tests of heterogeneity and bias in meta-analysis.
    Ioannidis JP
    J Eval Clin Pract; 2008 Oct; 14(5):951-7. PubMed ID: 19018930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 1: general issues and tail-area-based methods.
    Newcombe RG
    Stat Med; 2006 Feb; 25(4):543-57. PubMed ID: 16252269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing equivalence of two assays using sensitivity and specificity.
    Quiroz J; Burdick RK
    J Biopharm Stat; 2007; 17(3):433-43. PubMed ID: 17479392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [On the problem of missing data: How to identify and reduce the impact of missing data on findings of data analysis].
    Wirtz M
    Rehabilitation (Stuttg); 2004 Apr; 43(2):109-15. PubMed ID: 15100920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sample size formulas for estimating intraclass correlation coefficients with precision and assurance.
    Zou GY
    Stat Med; 2012 Dec; 31(29):3972-81. PubMed ID: 22764084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.